title: Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.
abstract: Mitotic regulatory pathways insure proper timing of mitotic entry, sister chromatid cohesion and separation, and cytokinesis. Disruption of this process results in inappropriate chromosome segregation and aneuploidy, and appears to contribute to cancer. Specifically, disregulation and somatic mutation of mitotic regulators has been observed in human cancers, and overexpression of mitotic regulators is common in aggressive and late stage tumors. However, the role of germline variation in mitotic pathways and risk of cancer is not well understood. We tested 1,084 haplotype-tagging and functional variants from 164 genes in mitotic regulatory pathways in 791 Caucasian women with breast cancer and 843 healthy controls for association with risk of overall and high grade breast cancer. Sixty-one single nucleotide polymorphisms (SNPs) from 40 genes were associated (P < 0.05) with risk of breast cancer in a log-additive model. In addition, 60 SNPs were associated (P < 0.05) with risk of high grade breast cancer. However, none of these associations were significant after Bonferroni correction for multiple testing. In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P < 0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both. Further investigation in breast and other cancers are needed to understand the influence of inherited variation in mitotic genes on tumor grade and cancer risk.
authors: Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
authors: Kristen N
authors: KN
authors: Stevens
authors: Xianshu
authors: X
authors: Wang
authors: Zachary
authors: Z
authors: Fredericksen
authors: V Shane
authors: VS
authors: Pankratz
authors: James
authors: J
authors: Cerhan
authors: Celine M
authors: CM
authors: Vachon
authors: Janet E
authors: JE
authors: Olson
authors: Fergus J
authors: FJ
authors: Couch
references: Breast Cancer Res Treat. 2011 Jan;125(1):221-8
references: 20508983
references: Nature. 2005 Oct 13;437(7061):1043-7
references: 16222300
references: Breast Cancer Res. 2005;7(2):R238-47
references: 15743504
references: Pathobiology. 2008;75(2):104-11
references: 18544965
references: Carcinogenesis. 2005 Aug;26(8):1368-73
references: 15802297
references: Cell Prolif. 2000 Oct;33(5):261-74
references: 11063129
references: Nat Genet. 2009 May;41(5):585-90
references: 19330027
references: Cancer Cell. 2007 Jan;11(1):9-23
references: 17189715
references: Gynecol Oncol. 2007 Oct;107(1):71-4
references: 17599395
references: Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1864-8
references: 19454617
references: Curr Biol. 2010 Mar 23;20(6):R285-95
references: 20334839
references: Genes Chromosomes Cancer. 1998 Mar;21(3):177-84
references: 9523192
references: Cancer Genet Cytogenet. 2002 Aug;137(1):1-7
references: 12377406
references: Breast Cancer Res Treat. 2010 Jan;119(2):453-62
references: 19404734
references: Mol Cell Biol. 2009 Aug;29(16):4363-75
references: 19528228
references: Cancer Cell. 2009 Dec 8;16(6):475-86
references: 19962666
references: Lab Invest. 1999 Apr;79(4):387-93
references: 10211991
references: Lung Cancer. 2008 Apr;60(1):31-39
references: 17961802
references: Breast Cancer Res Treat. 2010 Jan;119(2):423-30
references: 19377877
references: Int J Colorectal Dis. 2009 Feb;24(2):145-50
references: 18946675
references: Nature. 2008 Jul 17;454(7202):353-7
references: 18552837
references: J Med Genet. 2010 Sep;47(9):616-22
references: 20516147